T 2289/17 (Dry powder formulations / NOVARTIS) of 30.11.2021
- European Case Law Identifier
- ECLI:EP:BA:2021:T228917.20211130
- Date of decision
- 30 November 2021
- Case number
- T 2289/17
- Online on
- 16 December 2021
- Petition for review of
- -
- Application number
- 12705203.3
- IPC class
- A61K 45/06A61P 11/00A61K 31/58A61K 31/4704A61K 9/50A61K 31/56A61K 9/14A61K 9/00A61K 31/40A61M 15/00A61K 9/16
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- DRY POWDER FORMULATIONS OF PARTICLES THAT CONTAIN TWO OR MORE ACTIVE INGREDIENTS FOR TREATING OBSTRUCTIVE OR INFLAMMATORY AIRWAYS DISEASES
- Applicant name
- Novartis AG
- Opponent name
- Vectura Limited
- Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(a)European Patent Convention Art 56
- Keywords
- Inventive step - (yes)
- Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.